Bengaluru, October 6, 2026: Paediatric healthcare company Hoola Health has acquired UpTodd, an early-childhood development platform, and unveiled Hoola 1000 — a paediatrician-led programme that guides families from pregnancy through a child's second birthday. Registrations are now open ahead of the programme's launch in December 2026 in Bengaluru.
The programme takes its name from the first 1,000 days of a child's life, from conception to the second birthday, widely recognised as the most important window for a child's growth, brain development and long-term health. Built on UpTodd's early-childhood content and parent-engagement capabilities, Hoola 1000 combines guided paediatric care, specialist support and everyday guidance in one place. UpTodd has engaged over 100,000 families with milestone-driven content.
The multidisciplinary care team includes paediatricians, lactation consultants, nutritionists, sleep coaches and developmental therapists. Families get unlimited consultations via chat, video or in-person visits with no per-consultation charges, alongside daily nutrition plans, weekly play activities, monthly milestone reports and stage-wise toy and activity kits.
The acquisition targets a genuine gap in urban parenting. For most families, pregnancy comes with a clear structure of check-ups, scans and antenatal classes — after birth, that structure largely falls away, and parents piece together answers from search engines and social media. Hoola cites National Family Health Survey (NFHS-6) data showing that nearly four in ten babies in Karnataka are not exclusively breastfed through their first six months, arguing that what is missing is not intent but the right guidance at the right moment.
The deal folds UpTodd's content engine and 100,000-family parent base into Hoola Health's integrated paediatric care ecosystem for children and families.
Why it matters for founders
This is healthcare M&A as distribution strategy: a care-delivery company bought the content platform that owns the parent relationship. For founders in healthtech, the lesson is that trust and engagement — not just clinical capability — are the scarce asset, and acquiring them can be cheaper than building them.